132 related articles for article (PubMed ID: 11779889)
1. Aspirin and urinary 11-dehydrothromboxane B(2) in African American stroke patients.
Bruno A; McConnell JP; Mansbach HH; Cohen SN; Tietjen GE; Bang NU
Stroke; 2002 Jan; 33(1):57-60. PubMed ID: 11779889
[TBL] [Abstract][Full Text] [Related]
2. Serial urinary 11-dehydrothromboxane B2, aspirin dose, and vascular events in blacks after recent cerebral infarction.
Bruno A; McConnell JP; Cohen SN; Tietjen GE; Wallis RA; Gorelick PB; Bang NU
Stroke; 2004 Mar; 35(3):727-30. PubMed ID: 14963281
[TBL] [Abstract][Full Text] [Related]
3. Aspirin resistance in Indian patients with coronary artery disease and cardiovascular events.
Thomson VS; John B; George P; Joseph G; Jose J
J Postgrad Med; 2009; 55(4):252-6. PubMed ID: 20083870
[TBL] [Abstract][Full Text] [Related]
4. What is the lowest dose of aspirin for maximum suppression of in vivo thromboxane production after a transient ischemic attack or ischemic stroke?
Dippel DW; Van Kooten F; Leebeek FW; van Vliet HH; Mehicevic A; Li SS; Koudstaal PJ
Cerebrovasc Dis; 2004; 17(4):296-302. PubMed ID: 15026612
[TBL] [Abstract][Full Text] [Related]
5. Aspirin dosage and thromboxane synthesis in patients with vascular disease.
Hart RG; Leonard AD; Talbert RL; Pearce LA; Cornell E; Bovill E; Feinberg WM
Pharmacotherapy; 2003 May; 23(5):579-84. PubMed ID: 12741431
[TBL] [Abstract][Full Text] [Related]
6. Comparison of aspirin response measured by urinary 11-dehydrothromboxane B2 and VerifyNow aspirin assay in patients with ischemic stroke.
Dharmasaroja PA; Sae-Lim S
J Stroke Cerebrovasc Dis; 2014; 23(5):953-7. PubMed ID: 24126290
[TBL] [Abstract][Full Text] [Related]
7. Urinary 11-dehydro-thromboxane B(2) and coagulation activation markers measured within 24 h of human acute ischemic stroke.
McConnell JP; Cheryk LA; Durocher A; Bruno A; Bang NU; Fleck JD; Williams L; Biller J; Meschia JF
Neurosci Lett; 2001 Nov; 313(1-2):88-92. PubMed ID: 11684346
[TBL] [Abstract][Full Text] [Related]
8. Effects of different doses, enteric-coated preparation of aspirin, and sex on urinary 11-dehydrothromboxane B2 in healthy volunteers.
Dharmasaroja PA; Sae-Lim S
Blood Coagul Fibrinolysis; 2010 Oct; 21(7):649-52. PubMed ID: 20689403
[TBL] [Abstract][Full Text] [Related]
9. Aspirin, but not heparin, suppresses the transient increase in thromboxane biosynthesis associated with cardiac catheterization or coronary angioplasty.
Ciabattoni G; Ujang S; Sritara P; Andreotti F; Davies G; Simonetti BM; Patrono C; Maseri A
J Am Coll Cardiol; 1993 May; 21(6):1377-81. PubMed ID: 8473644
[TBL] [Abstract][Full Text] [Related]
10. Increased thromboxane biosynthesis is associated with poststroke dementia.
van Kooten F; Ciabattoni G; Koudstaal PJ; Grobbee DE; Kluft C; Patrono C
Stroke; 1999 Aug; 30(8):1542-7. PubMed ID: 10436098
[TBL] [Abstract][Full Text] [Related]
11. Experimental fat embolism induces urine 2,3-dinor-6-ketoprostaglandin F1alpha and 11-dehydrothromboxane B2 excretion in pigs.
Rautanen M; Gullichsen E; Riutta A; Kuttila K; Mucha I; Nelimarkka O; Niinikoski J
Crit Care Med; 1997 Jul; 25(7):1215-21. PubMed ID: 9233750
[TBL] [Abstract][Full Text] [Related]
12. Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events.
Eikelboom JW; Hirsh J; Weitz JI; Johnston M; Yi Q; Yusuf S
Circulation; 2002 Apr; 105(14):1650-5. PubMed ID: 11940542
[TBL] [Abstract][Full Text] [Related]
13. Cardioembolic vs. noncardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies.
Hart RG; Pearce LA; Miller VT; Anderson DC; Rothrock JF; Albers GW; Nasco E
Cerebrovasc Dis; 2000; 10(1):39-43. PubMed ID: 10629345
[TBL] [Abstract][Full Text] [Related]
14. Differential Impact of Serial Measurement of Nonplatelet Thromboxane Generation on Long-Term Outcome After Cardiac Surgery.
Kakouros N; Gluckman TJ; Conte JV; Kickler TS; Laws K; Barton BA; Rade JJ
J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29097390
[TBL] [Abstract][Full Text] [Related]
15. Statin therapy and inflammation in patients with diabetes treated with high dose aspirin.
Chaudhary R; Bliden KP; Garg J; Mohammed N; Tantry U; Mathew D; Toth PP; Franzese C; Gesheff M; Pandya S; Gurbel P
J Diabetes Complications; 2016; 30(7):1365-70. PubMed ID: 27237049
[TBL] [Abstract][Full Text] [Related]
16. Thromboxane and prostacyclin biosynthesis in patients with acute spontaneous intracerebral hemorrhage.
Saloheimo P; Juvela S; Riutta A; Pyhtinen J; Hillbom M
Thromb Res; 2005; 115(5):367-73. PubMed ID: 15733969
[TBL] [Abstract][Full Text] [Related]
17. Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Albers GW; Amarenco P; Easton JD; Sacco RL; Teal P
Chest; 2008 Jun; 133(6 Suppl):630S-669S. PubMed ID: 18574275
[TBL] [Abstract][Full Text] [Related]
18. Urinary 11-dehydro thromboxane B₂ levels in type 2 diabetic patients before and during aspirin intake.
Gonçalves LH; Dusse LM; Fernandes AP; Gomes KB; Sóter MO; Alves MT; Rodrigues KF; Freitas FR; Komatsuzaki F; Sousa MO; Bosco AA; Pianett GA; Carvalho Md
Clin Chim Acta; 2011 Jul; 412(15-16):1366-70. PubMed ID: 21510926
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic and pharmacodynamic differences between two low dosages of aspirin may affect therapeutic outcomes.
Cerletti C; Dell'Elba G; Manarini S; Pecce R; Di Castelnuovo A; Scorpiglione N; Feliziani V; de Gaetano G
Clin Pharmacokinet; 2003; 42(12):1059-70. PubMed ID: 12959636
[TBL] [Abstract][Full Text] [Related]
20. Statin therapy and thromboxane generation in patients with coronary artery disease treated with high-dose aspirin.
Bliden KP; Singla A; Gesheff MG; Toth PP; Tabrizchi A; Ens G; Guyer K; Singh M; Franzese CJ; Stapleton D; Tantry US; Gurbel PA
Thromb Haemost; 2014 Aug; 112(2):323-31. PubMed ID: 24763965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
